CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 40 enrolled
Drug / intervention
nicotinedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01702519
NCT01702519Phase 1Completed
CompareCT.gov

A Pharmacokinetic Evaluation of Two Nicotine Patches in Smokers

GlaxoSmithKline·interventional·Posted Oct 8, 2012·Updated Mar 20, 2015

In Brief

A Phase 1 clinical trial evaluating nicotine for Smoking. Completed, enrolled 40 participants across 1 site.

Detailed Summary

Bioequivalence study to confirm that a NTS with a polyisobutylene (PIB) adhesive from an alternative supplier delivers the same nicotine blood profile as that of the currently approved NTS with a polyisobutylene adhesive from the current supplier.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSmoking
CountriesUnited States
Collaborators--

Timeline

Phase 1CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedOct 8, 2012
Enrollment StartMar 1, 2012
Primary CompletionMar 1, 2012
TodayJul 2, 2026
Enrollment to primary: 0 daysPosted 13.7 years ago

Interventions

nicotinedrug

nicotine transdermal patch